NCTR Participation in 2024 FDA Omics Days
Precision in Practice: Regulatory Science, Best Practices, and Future Directions in Omics - September 12, 2024
2024 FDA Omics Days Poster Sessions(*Links to posters are PDF downloads) |
NCTR Authors |
|---|---|
| "Evaluation of RNA Extraction and Illumina NGS Library Preparation Methods to Detect Viral RNA from Different Sample Matrices" | B. Gong and J. Xu |
| “Evaluation of Plasma Proteome and miRNA Changes Related to COVID-19 Patient Severity Response” | R. Beger, L.-R. Yu, T. Han, V. Vijay, J. Sun, M. Bidarimath, E. Masters, T. Schmitt, L. Pence, K. Mercer, J. Hawes Oliphant |
| “Whole Genome Sequencing (WGS) Analyses: Room for the Benchtop?” | K. Feye, D. Sopovski, J. Revollo, J. Miranda-Colon, D. Gudeta, J. Han, S. Foley |
| “Understanding the Host Regulatory Circuits Behind Host Defense Against Flavivirus Infection” | B. Gong and J. Xu |
| “Untargeted Metabolomics and Lipidomics in COVID-19 Patient Plasma Reveals Severity Biomarkers” | R. Beger, L.-R. Yu, T. Han, V. Vijay, M. Bidarimath, E. Masters, T. Schmitt, L. Pence, K. Mercer, J. Hawes Oliphant, and J. Sun |
| “E. coli Exploits Co-Infection with Enterococcus faecalis to Enhance Biofilm Formation and Virulence on Antimicrobial Urinary Catheters” | K. Sung, M. Park, O. Kweon, A. Savenka, A. Paredes, and S.A. Khan |
| “Baseline Proteomic Biomarkers for Predicting Chemotherapy-Induced Cardiotoxicity in Breast Cancer Patients” | L.-R. Yu, Z. Cao, D. Wang, J.R. Daniels, and R.D. Beger |